ロード中...
Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
Recombinant factor VIIa (rFVIIa) can be used for rapid INR normalization in life-threatening hemorrhage in anticoagulated patients. Dosing is unclear and may carry thromboembolic risks. We reviewed the use of rFVIIa at a comprehensive stroke and cerebrovascular center to evaluate dose effectiveness...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4155054/ https://ncbi.nlm.nih.gov/pubmed/25197623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-471 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|